{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:52:10Z","timestamp":1793353930711,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2-TR002346"],"award-info":[{"award-number":["KL2-TR002346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaip.2023.05.023","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T12:11:16Z","timestamp":1685103076000},"page":"2767-2777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Beginning to Address an Implementation Gap in Asthma: Clinicians\u2019 Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-5481","authenticated-orcid":false,"given":"James G.","family":"Krings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas C.","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn V.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaharu","family":"Sumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee S.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber K.","family":"Clover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lenze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross C.","family":"Brownson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.05.023_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S2213-2600(20)30157-0","article-title":"Chronic respiratory diseases: a global view","volume":"8","author":"Labaki","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaip.2023.05.023_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.2004.00526.x","article-title":"The global burden of asthma: executive summary of the GINA Dissemination Committee report","volume":"59","author":"Masoli","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.023_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01046-2019","article-title":"GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents","volume":"53","author":"Reddel","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2013.10.028","article-title":"Asthma control in the United States, 2008-2010: indicators of poor asthma control","volume":"133","author":"Slejko","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.023_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2500\/aap.2011.32.3519","article-title":"Asthma burden in the United States: results of the 2009 Asthma Insight and Management survey","volume":"33","author":"Meltzer","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.05.023_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2500\/aap.2009.30.3276","article-title":"The status of asthma control in the U.S. adult population","volume":"30","author":"Fuhlbrigge","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.05.023_bib8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.2107057","article-title":"The burden of asthma in the United States: level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program guidelines","volume":"166","author":"Fuhlbrigge","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm6705e1","article-title":"Vital signs: asthma in children\u2014United States, 2001-2016","volume":"67","author":"Zahran","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2023.05.023_bib10","series-title":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.jaip.2023.05.023_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.socscimed.2019.03.040","article-title":"Mapping inequality: childhood asthma and environmental injustice, a case study of St. Louis, Missouri","volume":"230","author":"Harris","year":"2019","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib12","article-title":"Asthma progression and mortality: the role of inhaled corticosteroids","volume":"54","author":"O\u2019Byrne","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00901-2019","article-title":"Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study","volume":"54","author":"Dima","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00075614","article-title":"Medication adherence and the risk of severe asthma exacerbations: a systematic review","volume":"45","author":"Engelkes","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib15","first-page":"CD012226","article-title":"Interventions to improve adherence to inhaled steroids for asthma","volume":"4","author":"Normansell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2023.05.023_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","article-title":"Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD","volume":"107","author":"Makela","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib17","article-title":"Trends in inhaler prescriptions and associated cost in the United States from 2014 to 2018: an analysis from the Medicare Part D database","volume":"13","author":"Thomas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2023.05.023_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00625-2020","article-title":"SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis","volume":"56","author":"Rogliani","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0615","article-title":"Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis","volume":"5","author":"Beasley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2023.05.023_bib21","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O\u2019Byrne","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.05.023_bib24","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib25","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.05.023_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thoraxjnl-2013-203557","article-title":"Combination of budesonide\/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction","volume":"69","author":"Lazarinis","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2023.05.023_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(16)31399-X","article-title":"Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study","volume":"389","author":"Reddel","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.05.023_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1164\/rccm.202011-4236ED","article-title":"National Asthma Education and Prevention Program 2020 guideline update: where do we go from here?","volume":"203","author":"Krishnan","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib30","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jaip.2021.10.032","article-title":"2020 NAEPP guidelines update and GINA 2021\u2014asthma care differences, overlap, and challenges","volume":"10","author":"Chipps","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.023_bib31","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.2020.21974","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program","volume":"324","author":"Cloutier","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.05.023_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MCP.0000000000000862","article-title":"SMART\u2014is it practical in the United States?","volume":"28","author":"Norris","year":"2022","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib33","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A\u00a0practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106524","article-title":"Asthma patients\u2019 and physicians\u2019 perspectives on the burden and management of asthma","volume":"186","author":"Chapman","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12890-017-0492-5","article-title":"Physician perspectives on the burden and management of asthma in six countries: the Global Asthma Physician Survey (GAPS)","volume":"17","author":"Chapman","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106948","article-title":"Patients\u2019 and physicians\u2019 perspectives on the burden and management of asthma: results from the APPaRENT 2 study","volume":"201","author":"Chapman","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jaip.2023.05.023_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13012-016-0437-z","article-title":"A\u00a0systematic review of the use of the Consolidated Framework for Implementation Research","volume":"11","author":"Kirk","year":"2016","journal-title":"Implement Sci"},{"key":"10.1016\/j.jaip.2023.05.023_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13012-021-01111-5","article-title":"Rapid versus traditional qualitative analysis using the Consolidated Framework for Implementation Research (CFIR)","volume":"16","author":"Nevedal","year":"2021","journal-title":"Implement Sci"},{"key":"10.1016\/j.jaip.2023.05.023_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.jaip.2023.05.023_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13012-017-0550-7","article-title":"Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation","volume":"12","author":"Keith","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.jaip.2023.05.023_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12912-015-0088-4","article-title":"The Consolidated Framework for Implementation Research (CFIR): a useful theoretical framework for guiding and evaluating a guideline implementation process in a hospital-based nursing practice","volume":"14","author":"Breimaier","year":"2015","journal-title":"BMC Nurs"},{"key":"10.1016\/j.jaip.2023.05.023_bib43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/02770903.2019.1702200","article-title":"Using the Consolidated Framework for Implementation Research (CFIR) to evaluate implementation effectiveness of a facilitated approach to an asthma shared decision making intervention","volume":"58","author":"Shade","year":"2021","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2023.05.023_bib44","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.21037\/jtd.2019.01.29","article-title":"Use of the Consolidated Framework for Implementation Research to guide dissemination and implementation of new technologies in surgery","volume":"11","author":"Lambert-Kerzner","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaip.2023.05.023_bib45","series-title":"Mapping organizational readiness assessments to an implementation framework","author":"Miake-Lye","year":"2018"},{"key":"10.1016\/j.jaip.2023.05.023_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpubh.2020.00059","article-title":"Planning for implementation success using RE-AIM and CFIR frameworks: a qualitative study","volume":"8","author":"King","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.jaip.2023.05.023_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1186\/s12913-021-07024-9","article-title":"Using the Consolidated Framework for Implementation Research to design and implement a perinatal education program in a large maternity hospital","volume":"21","author":"Guyatt","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaip.2023.05.023_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232076","article-title":"A\u00a0simple method to assess and report thematic saturation in qualitative research","volume":"15","author":"Guest","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.05.023_bib49","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMp1716858","article-title":"Inhaled corticosteroids and LABAs\u2014removal of the FDA\u2019s boxed warning","volume":"378","author":"Seymour","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1378\/chest.102.2.535","article-title":"Rapid onset of action of inhaled formoterol in asthmatic patients","volume":"102","author":"Wegener","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2023.05.023_bib51","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1183\/09031936.97.10112489","article-title":"Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency","volume":"10","author":"Palmqvist","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-021-00067-z","article-title":"ICS\/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy","volume":"7","author":"Cruz","year":"2021","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.jaip.2023.05.023_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2016.38","article-title":"The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis","volume":"26","author":"DiSantostefano","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib54","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa2118813","article-title":"Reliever-triggered inhaled glucocorticoid in Black and Latinx adults with asthma","volume":"386","author":"Israel","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106568","article-title":"A\u00a0patient decision aid for mild asthma: navigating a new asthma treatment paradigm","volume":"201","author":"Gagne","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib56","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaip.2023.01.002","article-title":"The ICS\/formoterol reliever therapy regimen in asthma: a review","volume":"11","author":"Beasley","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.023_bib57","first-page":"73","article-title":"Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines 2020: a quick reference guide","volume":"133","author":"Beasley","year":"2020","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.jaip.2023.05.023_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1164\/rccm.202209-1729PP","article-title":"A\u00a0call for the United States to accelerate the implementation of reliever combination inhaled corticosteroid-formoterol inhalers in asthma","volume":"207","author":"Krings","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02073-2019","article-title":"Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial","volume":"55","author":"Baggott","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.023_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106154","article-title":"Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study","volume":"175","author":"Foster","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.023_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11414-015-9475-6","article-title":"Methods to improve the selection and tailoring of implementation strategies","volume":"44","author":"Powell","year":"2017","journal-title":"J\u00a0Behav Health Serv Res"},{"key":"10.1016\/j.jaip.2023.05.023_bib62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2022.07.005","article-title":"Strategies to improve the implementation of infection control link nurse programmes in acute-care hospitals","volume":"128","author":"Dekker","year":"2022","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jaip.2023.05.023_bib63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/geront\/gnac157","article-title":"Identification of implementation strategies using the CFIR-ERIC matching tool to mitigate barriers in a primary care model for older veterans","volume":"63","author":"Shin","year":"2023","journal-title":"Gerontologist"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:52:38Z","timestamp":1778853158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823005615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213219823005615"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beginning to Address an Implementation Gap in Asthma: Clinicians\u2019 Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}